⚫
Long-term morbidity rate is low. (LoE: III)
⚫
Technical advances improve tumor control and
lower toxicity.
⚫
Careful patient selection is important to avoid
unacceptable morbidity.
⚫
Urgent need for prospective trials to investigate
on medical approaches to the treatment of
morbidity.
Summary of first presentation




